PDCD1 and neoplasm: As a result, the tumor‐to‐background ratio significantly increased by 3.8‐fold (from 1.1 to 4.2) in Q‐annexin V‐injected mice following anti‐PD‐1/4‐1BB treatment (Figure 7b).